[go: up one dir, main page]

ES469749A1 - A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL FORMULATION OF A NOTROIMIDAZOLE DRUG. - Google Patents

A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL FORMULATION OF A NOTROIMIDAZOLE DRUG.

Info

Publication number
ES469749A1
ES469749A1 ES469749A ES469749A ES469749A1 ES 469749 A1 ES469749 A1 ES 469749A1 ES 469749 A ES469749 A ES 469749A ES 469749 A ES469749 A ES 469749A ES 469749 A1 ES469749 A1 ES 469749A1
Authority
ES
Spain
Prior art keywords
preparation
pharmaceutical formulation
drug
notroimidazole
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES469749A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES469749A1 publication Critical patent/ES469749A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

A process for the preparation of a pharmaceutical formulation of a nitroimidazole drug consisting of treating the nitroimidazole drug with an aqueous solution of a pharmaceutically acceptable salt of a mono- or di-hydroxybenzoic acid or of a mono- or di-hydroxybenzyl alcohol, sterilize and, if desired, lyophilize the resulting solution. (Machine-translation by Google Translate, not legally binding)
ES469749A 1977-05-14 1978-05-11 A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL FORMULATION OF A NOTROIMIDAZOLE DRUG. Expired ES469749A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2037977 1977-05-14

Publications (1)

Publication Number Publication Date
ES469749A1 true ES469749A1 (en) 1978-12-16

Family

ID=10144988

Family Applications (1)

Application Number Title Priority Date Filing Date
ES469749A Expired ES469749A1 (en) 1977-05-14 1978-05-11 A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL FORMULATION OF A NOTROIMIDAZOLE DRUG.

Country Status (16)

Country Link
JP (1) JPS542315A (en)
AU (1) AU504551B1 (en)
BE (1) BE867040A (en)
DE (1) DE2820992A1 (en)
DK (1) DK212678A (en)
ES (1) ES469749A1 (en)
FI (1) FI781507A (en)
FR (1) FR2390162A1 (en)
IL (1) IL54687A0 (en)
IT (1) IT1115599B (en)
LU (1) LU79655A1 (en)
NL (1) NL7805158A (en)
NO (1) NO781688L (en)
PT (1) PT68034B (en)
SE (1) SE7805471L (en)
ZA (1) ZA782736B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024023B2 (en) * 1979-08-11 1992-11-11 Bayer Ag Antimycotic agents with enhanced release of the active ingredients
FR2624736B1 (en) * 1987-12-16 1991-03-22 Dietlin Francois NEW WATER-DISPERSIBLE PHARMACEUTICAL COMPOSITIONS BASED ON ORNIDAZOLE
CN104127379A (en) * 2014-08-14 2014-11-05 珠海亿邦制药股份有限公司 Ornidazole injection and preparation method thereof
CN110538144A (en) * 2019-06-13 2019-12-06 南京瓦尔生物医药有限公司 Ornidazole injection and S-ornidazole injection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4032645A (en) * 1975-06-19 1977-06-28 G. D. Searle & Co. Injectable metronidazole composition

Also Published As

Publication number Publication date
IT1115599B (en) 1986-02-03
IL54687A0 (en) 1978-07-31
NL7805158A (en) 1978-11-16
JPS542315A (en) 1979-01-09
AU504551B1 (en) 1979-10-18
NO781688L (en) 1978-11-15
PT68034A (en) 1978-06-01
FI781507A (en) 1978-11-15
SE7805471L (en) 1978-11-15
PT68034B (en) 1979-10-24
ZA782736B (en) 1979-05-30
FR2390162A1 (en) 1978-12-08
IT7823351A0 (en) 1978-05-12
DK212678A (en) 1978-11-15
LU79655A1 (en) 1979-12-06
DE2820992A1 (en) 1978-12-07
BE867040A (en) 1978-11-13

Similar Documents

Publication Publication Date Title
PT97689A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS INCORPORATING AS ACTIVE INGREDIENT ISOXAZOL-4-CARBOXYLAMIDE AND HYDROXYLYLIDENE-CYANOOCETAMIDE
SE8701900D0 (en) PULSED DRUG DELIVERY
GB2007091A (en) Ophthalmic composition
SE8402551D0 (en) CINNAMOYLMORANOLIN DERIVATIVES
EE03292B1 (en) Multiple drug formulation containing a proton pump inhibitor and process for its preparation
SE7613959L (en) ANTIBIOTIC COMPOSITION AND PROCEDURE FOR PREPARING IT
MX27046A (en) 5-ARILALQUIL-4-ALCOXY-2 (5H) -FURANONAS, INTERMEDIATE PRODUCTS AND PROCEDURE FOR ITS PREPARATION AS WELL AS ITS APPLICATION AS AN ACTIVE THERAPEUTIC SUBSTANCE.
ES485062A1 (en) A procedure for preparing acetic acid derivatives (Machine-translation by Google Translate, not legally binding)
RU93032613A (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PATIENTS WITH PROLONGED COAGULATION TIME, METHOD OF TREATING PATIENTS, USING THE EPI INHIBITOR FOR OBTAINING THE PHARMACEUTICAL PREPARATION
SE7902742L (en) DISUBSTITUTED 3-CEFEM-4-CARBOXYLIC ACID DERIVATIVES AND PROCEDURES FOR THE PREPARATION
IT7820972A0 (en) DERIVATIVES OF PHENOXIC & PHENOXIC ACIDS, ALCANES, ACTIVE CARBOXYLICS AS HERBICIDES AND PROCEDURE FOR THEIR PREPARATION.
ES2033021T3 (en) AGENT WITH DESTRUCTIVE EFFECT TO MALIGNANT TUMORS, PROCEDURE FOR THEIR OBTAINING AND PREPARATION FOR THE APPLICATION IN THE THERAPY OF CANCER PATIENTS.
ES2145360T3 (en) CRYSTALLINE SALTS AND STABLE TETRAHYDROPHOLIC ACID.
FR2581382B1 (en) N- (QUINOLYL) GLYCINAMIDE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION AS PSYCHOTROPES
IT7922743A0 (en) CONTROLLED EMISSION PHARMACEUTICAL DOSAGE COMPONENT.
ES469749A1 (en) A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL FORMULATION OF A NOTROIMIDAZOLE DRUG.
FR2340330A1 (en) POLYVINYLBENZENESULPHONIC ACIDS, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICINAL PRODUCTS
ES410825A1 (en) Quinoline derivatives
FR2387221A1 (en) BENZIMIDAZOLE DERIVATIVES FOR USE AS ACTIVE SUBSTANCES IN VETERINARY MEDICINAL PRODUCTS
SE7902866L (en) 3-0- (BETA-D-GLUCURONOPYRANOSYL) -SOJASAPOGENOL B
NO156900C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3,4-OCSADIAZOLYLPHENOL DERIVATIVES.
IT7926854A0 (en) CREATINOL O-PHOSPHATE DERIVATIVE WITH THERAPEUTIC ACTION, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
IT8020100A0 (en) MEDICAMENT, OR PHARMACEUTICAL PREPARATION, WITH CYTOSTATIC ACTION.
IT7823102A0 (en) DERIVATIVES OF AZOLYL-ALKAN-CARBOXYLIC ACIDS, PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS FUNGICIDES.
IT1159101B (en) PROCEDURE FOR THE TREATMENT OF NEONATAL COLIBACILLOSIS AND ITS PHARMACEUTICAL COMPOUND